Skip to main content
. 2024 Sep 3;14:1450889. doi: 10.3389/fonc.2024.1450889

Figure 1.

Figure 1

Comparison between the basal FDG-PET and the FDG-PET performed after two weeks of imatinib therapy. (A) High tracker uptake in liver metastasis at baseline. (B) Complete metabolic response in liver metastasis after two weeks of imatinib therapy. (C) High tracker uptake in peritoneal metastasis at baseline. (D) Near-complete metabolic response in peritoneal metastasis after two weeks of imatinib therapy.